about
Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control studyPlanning against biological terrorism: lessons from outbreak investigationsHigh frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania.Incorporation of real-time PCR into routine public health surveillance of culture negative bacterial meningitis in São Paulo, Brazil.Effect of pneumococcal conjugate vaccine on pneumococcal meningitisLeptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000.Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.Geotemporal analysis of Neisseria meningitidis clones in the United States: 2000-2005.Screening for methicillin-resistant Staphylococcus aureus colonization using sponges.Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeClinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United StatesErythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999-2001.Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance.Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms.Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131.Association of relapse of Clostridium difficile disease with BI/NAP1/027.Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.Infection and readmission rate of cardiac implantable electronic device insertions: An observational single center study.Influenza vaccination rates and motivators among healthcare worker groups.Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.Leptospirosis among patients presenting with dengue-like illness in Puerto Rico.Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure.Meningococcal carriage among Georgia and Maryland high school students.Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysisFast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR.Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients.Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection.Risk factors for meningococcal disease in college students.Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000.A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru.Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach.Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?Multi-locus variable number tandem repeat analysis for investigation of the genetic association of Clostridium difficile isolates from food, food animals and humans.Antigenic Shift and Increased Incidence of Meningococcal DiseaseRisk Factors for Meningococcal Disease in Students in Grades 9–12Opportunistic Infections in 547 Organ Transplant Recipients Receiving Alemtuzumab, a Humanized Monoclonal CD-52 Antibody
P50
Q28298477-8023DEAB-D385-4072-9166-63BED8D2D187Q30233417-957CBE62-8D75-484F-B52D-308399A95781Q33641352-E8417468-7327-4C10-AFC1-D73B544E76E6Q33729202-2E383118-B5FE-4A35-824E-994047D6E566Q33900157-DBE63BDC-4EF2-4A6B-9A61-FF8EA7423501Q33952107-66B24883-C9A4-4E6D-B6CE-C8BF5D426BA2Q34015633-EC8C5C9E-8E1B-47F0-B413-1B74BBE179BBQ34396402-4DFD748E-845C-45F3-9C94-4E74512CA94DQ34529235-E8C82E43-80DD-4640-9220-E113FB053A16Q35069945-275303BD-D4CA-434A-A988-5FC304B772A3Q35742335-11B53BD3-3CBE-48D0-B8D7-CC9A24BF0B41Q35861216-7161EF7D-8AB1-462E-A9BF-890C92347DA1Q35867321-F292B79F-38E2-4E68-80D3-48991C4900BFQ36009349-7FD22250-DEF9-4753-AD86-A7447A0C85ADQ36290521-98EDC4DB-48D2-491A-AD4B-D1D65AEC1D75Q36313244-26EFA7B0-03A5-496E-ACE7-287A403D01A8Q36379396-D48F50CB-1A86-4BFB-A80C-5776B7EC614DQ36414097-6E663F72-1AA6-43F4-97D9-C53E75D89995Q36584908-67E9D6BA-3668-452D-AF70-F6F9E875FB3CQ36603664-6D82B2F5-DCF6-462C-96FD-3A9DD5ADE1CEQ38679678-A4514713-C485-4611-AF9A-810EB629A224Q39784119-EC104C88-8244-4412-B6CD-4AC64C82A55DQ39920363-DAA5D5AB-99A3-4840-A4B3-8A4BD0A90A2BQ40501947-B3CF44BF-632F-4A07-BF9A-E2B2D52C48B4Q41565209-72B6BFF3-90DA-4295-93C4-47D1279AED02Q41600060-F8CFDA98-9DD3-4E8E-BF45-DF8D3CB86088Q41769329-6E40828F-AE53-4177-B401-0FEAD9B472C9Q42286770-F8BC4873-BB99-43F0-995F-C8878021FADEQ42873320-D81C52BE-215A-4D7D-88CE-E10FE3D25351Q44084276-DFA7AADA-26B3-4644-852D-FA12EA5BB154Q44937042-1AB4E8B9-31EF-4ACB-8652-04066F04917FQ46343974-92D4ED70-2E8E-48A5-902A-B4771E07DA64Q46408982-81FBDE56-2CFE-4C0D-8919-4EF67F9B78AEQ50712094-B4CE4FF9-DE09-414F-A984-A2D2EC0E5B32Q51109086-12BD435D-F266-4554-A242-1EBBF247178DQ51907741-1B2F2685-5F20-44E6-BF1F-BA9BA430CB33Q53786884-9DD89CAA-DD75-4478-8488-954408118381Q57707003-23D29F02-3D03-4154-B61F-0C7E34A1678CQ59230685-8F512F48-FFB8-4AF1-AE0D-0D1C1BD9EA94Q59230712-A59CF683-B841-4634-99A7-A137879D59D9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kathleen A Shutt
@nl
Kathleen A Shutt
@sl
Kathleen A. Shutt
@en
Kathleen A. Shutt
@es
type
label
Kathleen A Shutt
@nl
Kathleen A Shutt
@sl
Kathleen A. Shutt
@en
Kathleen A. Shutt
@es
prefLabel
Kathleen A Shutt
@nl
Kathleen A Shutt
@sl
Kathleen A. Shutt
@en
Kathleen A. Shutt
@es
P106
P1153
6603143734
P21
P31
P496
0000-0003-3376-6152